BridgeMD
New treatment option for Pain
Official title A Handheld Tool for Active Distraction of Children and Adolescents During Painful Procedures
ClinicalTrials.gov ID: NCT06984939
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if the handheld device Grasp, works to reduce pain and distress during small procedures involving a needle prick in children and adolescents. The main question it aims to answer is: Does repetitive squeezing of the Grasp device during the painful procedure affect self-reported pain and distress?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 15
You may be able to join if
- Written consent has been obtained from the parents or legal guardians.
- Age 8-15 years old One of the following:
- Attend the Child and Youth Clinic at Haukeland University Hospital for peripheral venous cannula insertion
- Attend the Helsebanken in Øystese for blood sampling
- Attend TKVestland for planned dental treatment involving local anesthesia administered via injection (needle)
You likely can't join if
- Moderate to severe intellectual disability
- Impaired vision or hearing
- Does not understand the Norwegian language
- General condition affected by illness
- Anticipated use of sedation during the procedure (e.g., Midazolam)
- Previous participation in this study
See the full eligibility criteria
- Written consent has been obtained from the parents or legal guardians.
- Age 8-15 years old One of the following:
- Attend the Child and Youth Clinic at Haukeland University Hospital for peripheral venous cannula insertion
- Attend the Helsebanken in Øystese for blood sampling
- Attend TKVestland for planned dental treatment involving local anesthesia administered via injection (needle)
- Admitted to the Child and Youth Clinic at Haukeland University Hospital for the first time due to type 1 diabetes mellitus, requiring frequent blood glucose measurements and insulin injections.
- Moderate to severe intellectual disability
- Impaired vision or hearing
- Does not understand the Norwegian language
- General condition affected by illness
- Anticipated use of sedation during the procedure (e.g., Midazolam)
- Previous participation in this study
The study team makes the final eligibility decision.
Where it's taking place
- Bergen, Vestland, Norway
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 15 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bergen, Vestland, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.